These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6530763)

  • 21. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
    Carlsten H; Holmdahl R; Tarkowski A
    Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
    Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
    J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
    Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
    Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN; Thurman J; Izui S; Falta MT; Metzger TE; Flannery SA; Kappler J; Marrack P; Kotzin BL
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice.
    Ikehara S; Shimamura K; Aoyama T; Fujii S; Hamashima Y
    Immunology; 1985 Aug; 55(4):595-600. PubMed ID: 4018844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.
    Jacob CO; McDevitt HO
    Nature; 1988 Jan; 331(6154):356-8. PubMed ID: 2893286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [NZB/W mice: an animal model of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(2):217-23. PubMed ID: 1083547
    [No Abstract]   [Full Text] [Related]  

  • 30. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged survival of hypertransfused NZB/NZW mice.
    Gabrielsen AE; Olsen CT
    Immunology; 1977 Oct; 33(4):449-52. PubMed ID: 924516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiotypic analysis and suppression of autoantibodies to DNA in (NZB X NZW)F1 mice.
    Tron F; Jacob L; Bach JF
    Monogr Allergy; 1987; 22():81-8. PubMed ID: 3501839
    [No Abstract]   [Full Text] [Related]  

  • 33. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three genes for lupus nephritis in NZB x NZW mice.
    Knight JG; Adams DD
    J Exp Med; 1978 Jun; 147(6):1653-60. PubMed ID: 681876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.
    Adelman NE; Watling DL; McDevitt HO
    J Exp Med; 1983 Oct; 158(4):1350-5. PubMed ID: 6578293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causal association between major histocompatibility complex and myocardial infarction in NZW x BXSB F1 mice.
    Kawano H; Kawano Y; Shirai T; Okada R
    Jpn Circ J; 1995 Feb; 59(2):98-102. PubMed ID: 7596028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.
    Passwell JH; Schreiner GF; Wetsel RA; Colten HR
    Immunology; 1990 Oct; 71(2):290-4. PubMed ID: 2228028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The E-linked subregion of the major histocompatibility complex down-regulates autoimmunity in NZB x NZW F1 mice.
    Hirose S; Zhang D; Nozawa S; Nishimura H; Shirai T
    Immunogenetics; 1994; 40(2):150-3. PubMed ID: 8026863
    [No Abstract]   [Full Text] [Related]  

  • 40. [The relationship between murine lupus nephritis and thymic abnormalities].
    Tanaka H; Ikehara S; Furukawa F; Sekita K; Nakamura T; Inoue S; Hamashima Y
    Nihon Jinzo Gakkai Shi; 1984 Aug; 26(8):1069-77. PubMed ID: 6513178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.